Navigation Links
OcuLight GLx

ProductsOcuLight GLx
Company IRIDEX
Item OcuLight GLx
Features 
Description Using the latest in solid-state technology, this laser emit true continuous-wave (TrueCW) green light at 532 nm. Patented solid-state technology offers unsurpassed reliability, multiple delivery device options maximize versatility, compact size allows easy transportation between offices, and advanced design minimizes any routine laser maintenance. The EasyFit Adapter converts specific slit lamps into an integrated laser/slit lamp workstation in combination with the OcuLight GLx (532 nm) laser. Portable Slit Lamp Adapters can attach to over 50 models of Haag-Streit, Zeiss and similar type slit lamps to add the therapeutic capability of transpupillary laser photocoagulation to most standard slit lamps. The Integrated Laser/Slit Lamp Workstation is compatible with the OcuLight GLx and includes a laser delivery device with 50-1000 m parfocal zoom spot size adjustment, self-centering micromanipulator and electronic eye safety filter that rotates in for laser treatment and rotates out for unfiltered diagnostic viewing.
Info IRIDEX
Customer Service: (800) 388-9087
Web site: http://www.iridex.com/ophthalmology/index.html

Related medicine products :

1. OcuLight SL
2. OcuLight GL
3. OcuLight SLx
4. OcuLight OR Green Laser Photocoagulator
Overall length 355 mm, 14.0 inches.
Fluoroperm 151 lens meets special needs of certain patients who need exceptional oxygen permeability for specific corneal condition or lifestyle requirements.
Magniclear is the first presbyopic lens to combine the clear distance optics of a spherical lens, the intermediate visual performance of a multifocal and the predictably crisp, near power of a bifoca
... the Polycon II lens design with the exceptional p...thin lens that offers predictable fitting, crisp v...urability and superior oxygen delivery. Combined w...r service and expedited delivery, Artcon is the pe...
Medicine Products:
(Date:11/21/2008)...na would. So would Emily Litella and Baba Wawa. No...pport them, can help fund operations at Gilda&rsqu...hases with the new Gilda’s Club NYC Visa Pla...Business Wire EON) November 21, 2008 -- Gilda,s C...n ongoing share of the monthly charge volume. Proc...
(Date:11/21/2008)...ion, ClinicalIQ LLC, and Pharmacy OneSource, Inc t...o, USP < 797 > for the healthcare industry. ...-- Baxa Corporation has teamed up with industry le... to convey a complete compliance solution for the ... < 797 > regulations. The alliance among th...
(Date:11/21/2008)...eryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) to...ed notice from The Nasdaq Stock Market ("Nasdaq") ...e with Marketplace Rule 4310(c)(3), which requires...ockholders, equity, or $35,000,000 market value of... continuing operations for the most recently compl...
(Date:11/21/2008)...tCall/ -- DATATRAK,International, Inc. (Nasdaq: ...,on global eClinical solutions for the clinical t...partner in Japan, NTT DATA Corporation, has placed...AK eClinical platform into production,for a Japan...s first,independently designed clinical trial fol...
Breaking Medicine News(10 mins):Health News: Gilda's Club NYC Offers Affinity Credit Card to Help New Yorkers Living with Cancer 2Health News:Baxa Corporation Announces Co-Marketing Agreement With Industry Leaders Pharmacy OneSource, Inc and ClinicalIQ LLC 2Health News:Baxa Corporation Announces Co-Marketing Agreement With Industry Leaders Pharmacy OneSource, Inc and ClinicalIQ LLC 3Health News:Baxa Corporation Announces Co-Marketing Agreement With Industry Leaders Pharmacy OneSource, Inc and ClinicalIQ LLC 4Health News:Keryx Biopharmaceuticals Receives Nasdaq Notification 2Health News:Keryx Biopharmaceuticals Receives Nasdaq Notification 3Health News:NTT DATA Launches First Self-Designed DATATRAK eClinical(TM) Project Into Production in Japan 2Health News:NTT DATA Launches First Self-Designed DATATRAK eClinical(TM) Project Into Production in Japan 3
...are being diagnosed for diabetes type 2 may have i...ess at the onset of the disease. A study done by t...delphia have shown that among the children who are...isease, two out of five of them have showed tenden...
...ionizing the treatment of male impotence latest re...elp children with a fatal lung disease walk furthe...onary arterial hypertension ( PAH) a condition in ...eries that supply the lungs, leads to narrowing of...
...intake of vegetables in childhood lower risk// of ...vascular mortality was examined in a very interest...ascular disease, which occurs in adults is not jus...lthood but is more of an accumulated event over an...
... of new disease like SARS, Ebola, Marburg and Avia.../ are looked into from a global perspective. In an...ife Conservation Society of US have suggested that...m the standpoint of individual countries that are ...
Other Medicine News:Health News:Association between childhood diet and stroke 2
(Date:11/20/2008)...SNewswire/ -- The following is being released by C...WHAT: World AIDS Day Audio Media Conference , ... 11:00 a.m. EST , Call-in number: 1-800-949-8...dytalk.com/r/1xe41i2yre8rs , , WHY: With... newly put on treatment worldwide, advocates are c...
(Date:11/20/2008)...r 20 Arpida (SWX:,ARPN)...isory Committee of the,U.S. Food and Drug Adminis...val of intravenous iclaprim, an antibiotic current...ith complicated skin and skin structure infections...resistant Staphylococcus,aureus (MRSA). , ...
(Date:11/20/2008)...wire/ -- Radius Health ("Radius") announced today ...s second institutional financing round, increasing...e total amount raised since the company,s inceptio...vestors participated in the financing, led by MPM ...l, The Wellcome Trust, HealthCare Ventures, Oxford...
(Date:11/19/2008)...e/ -- Posit Science Corporation,researcher, Dan T...science,Annual Conference in Washington, DC this ...it Baby Boomers. The computerized brain plasticit...exercises that target auditory and,language syste...ed,improvements in cognition by improving speed a...
Breaking Medicine Technology:Faith and Civil Society Leaders Call for Truth and Leadership in U.S. HIV Prevention Efforts 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Elbit Medical Imaging Ltd Announces Definitive Agreements for a Large Scale Luxury Mixed Use Project in Bangalore India 1401 1Elbit Medical Imaging Ltd Announces Definitive Agreements for a Large Scale Luxury Mixed Use Project in Bangalore India 1401 2Elbit Medical Imaging Ltd Announces Definitive Agreements for a Large Scale Luxury Mixed Use Project in Bangalore India 1401 3Elbit Medical Imaging Ltd Announces Definitive Agreements for a Large Scale Luxury Mixed Use Project in Bangalore India 1401 4Patient Enrollment Complete in First Trial to Compare Physiologic Guidance vs Angiographic Guidance of Stent Deployment in Patients with Multivessel 587 1Patient Enrollment Complete in First Trial to Compare Physiologic Guidance vs Angiographic Guidance of Stent Deployment in Patients with Multivessel 587 2A longer living healthier mouse that could hold clues to human aging 4239 1A longer living healthier mouse that could hold clues to human aging 4239 2Elsevier journals participate widely in global theme issue on poverty and human development 4235 1Elsevier journals participate widely in global theme issue on poverty and human development 4235 2
... Three NCI-Sponsored Clinical Trials , SOUTH SAN F...rated (Nasdaq: CYTK) announced results from the an...sib administered as,monotherapy, one in patients w...lanoma, and one in patients with hormone-refractor...cule inhibitor of,kinesin spindle protein (KSP), a...
...-A cervical cancer vaccine has shown 90%,efficacy ... lesions,associated with the human papillomavirus ...ors of an Article published early Online,and in th...18 account for 70% or more,cases of cervical cance...types which can contribute to cervical cancer. , P...
Other Medicine Technology:Cytokinetics Reports Additional Clinical Trials Data for Ispinesib 2Cytokinetics Reports Additional Clinical Trials Data for Ispinesib 3Cytokinetics Reports Additional Clinical Trials Data for Ispinesib 4Cytokinetics Reports Additional Clinical Trials Data for Ispinesib 5Cytokinetics Reports Additional Clinical Trials Data for Ispinesib 6Cytokinetics Reports Additional Clinical Trials Data for Ispinesib 7Cytokinetics Reports Additional Clinical Trials Data for Ispinesib 8Vaccine Can Prevent Cervical Cancer and Precancerous Lesions 2